Zymergen
Machine learning-driven microbial strain engineering platform for producing bio-based materials and chemicals
- Sector
- Biotech
- Headquarters
- EMERYVILLE, CA
- Founded
- 2013
- Latest Form D
- $406M, Dec 2018
- Total capital
- $581M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $580M
- 3 Form D · last Dec 2018
- 94 months since last filing
- Federal contracts
- $267K
- 1 award · Defense
- Rank in Biotech#278 of 4373
- Granted patents
- 9
- 31 pending · first 2022
- Rank in peer group#6 of 342
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$406M
- Private capital raisedForm D · SEC · 2nd filing$130M
- Private capital raisedForm D · SEC · 1st filing$44.1M
- Federal contractDefense · Living Foundries Seedling Effort - This Effort Will Develop A Software Tool For Searching Existing And Custom Databases Of Chemical Compounds. This New Type Of Search Portal Will Enable Chemists And Material Scientists To Upload And Search Custom Databases Of Compounds To Identify Biological Building Blocks Of Interest Using A Multipart Search Statement Of Their Own Design.$267K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
16months
from Zymergen’s first federal award to its first private round.
- First federal award · Feb 2014
- Defense · $267K
- First Form D · Jun 2015
- $44.1M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 342 peers
Line = medianBiotech · Platform
- Granted patents#6 · top 2%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Aaron KimballExecutive OfficerNamed in SEC Form D filings
- Deep NisharDirectorNamed in SEC Form D filings
- Duane ValzExecutive OfficerNamed in SEC Form D filings
- Enakshi SinghExecutive OfficerNamed in SEC Form D filings
- Erik (Jed) DeanExecutive OfficerNamed in SEC Form D filings
- Jed DeanExecutive OfficerNamed in SEC Form D filings
Show all 17 people
- Joshua HoffmanExecutive Officer, DirectorNamed in SEC Form D filings
- Judy GilbertExecutive OfficerNamed in SEC Form D filings
- Matt OckoDirectorNamed in SEC Form D filings
- Paul JansenDirectorNamed in SEC Form D filings
- Richard PietersExecutive OfficerNamed in SEC Form D filings
- Rohit SharmaDirectorNamed in SEC Form D filings
- Sandra MileyExecutive OfficerNamed in SEC Form D filings
- Steven ChuDirectorNamed in SEC Form D filings
- Tom StephensonExecutive OfficerNamed in SEC Form D filings
- Zachariah SerberExecutive Officer, DirectorNamed in SEC Form D filings
- Zach SerberExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 9 granted of 40- PendingEnergy Storage Application Electrolytes And Electrode Compositions Comprised Of HeterocycleUSPTOApplication 18576624
- PendingEngineered Biosynthetic Pathways For Production Of Deoxyhydrochorismic Acid By FermentationUSPTOApplication 17925593
- PendingHexadepsipeptide Compounds And Methods Of Using The SameUSPTOApplication 18547321
Show all 40 patent records
- Energy Storage Application Electrolytes And Electrode Compositions Comprised Of HeterocycleNov 7, 2024 · Application 18576624Pending
- Engineered Biosynthetic Pathways For Production Of Deoxyhydrochorismic Acid By FermentationJul 11, 2024 · Application 17925593Pending
- Hexadepsipeptide Compounds And Methods Of Using The SameMay 2, 2024 · Application 18547321Pending
- Engineered Biosynthetic Pathways for Production of Histamine by FermentationApr 18, 2024 · Application 18349895Pending
- Genomic Engineering Of Biosynthetic Pathways Leading To Increased NadphFeb 29, 2024 · Application 18045098Pending
- Methods To Identify Novel Insecticidal Proteins From Complex Metagenomic Microbial SamplesJan 11, 2024 · Application 18022848Pending
- Engineered Biosynthetic Pathways For Production Of Ectoine By FermentationDec 14, 2023 · Application 17917549Pending
- Laboratory Automation System Implementing Efficient Path For Material And Labware TransfersDec 12, 2023 · US 11,841,374Granted
- Engineered Biosynthetic Pathway For Production Of 4-AMINOPHENYLETHYLAMINE By FermentationDec 7, 2023 · Application 18021788Pending
- High-throughput Methods For The Detection Of Ectopic Integration Of Transforming DnaNov 2, 2023 · Application 18021747Pending
- Methods Of Transient Protein And Gene Expression In CellsOct 26, 2023 · Application 17927336Pending
- Catechol Modifiers For Epoxy AdhesivesOct 12, 2023 · Application 18020754Pending
- Optical FilmAug 31, 2023 · Application 18013078Pending
- Engineered Biosynthetic Pathways For Production Of Histamine By FermentationAug 29, 2023 · US 11,739,355Granted
- A Modular And Pooled Approach For Multiplexed Crispr Genome EditingAug 24, 2023 · Application 18017956Pending
- Method for Producing Optical Film Containing Polyimide-Based ResinAug 10, 2023 · Application 18013085Pending
- Method for Producing Long Optical Film Containing Polyimide-Based ResinAug 3, 2023 · Application 18013081Pending
- Dimers From Bioreachable Molecules As CopolymersAug 3, 2023 · Application 18003482Pending
- Optical FilmAug 3, 2023 · Application 18013075Pending
- A Htp Platform For The Genetic Engineering Of Chinese Hamster Ovary CellsJul 27, 2023 · Application 18166746Pending
- Rapid Removal Of A Self-replicating Fungal Plasmid For Efficient Marker CyclingJul 13, 2023 · Application 18155552Pending
- Hydrogenation Of NepetalactoneJun 22, 2023 · Application 17995920Pending
- Metagenomic Library And Natural Product Discovery PlatformJun 15, 2023 · Application 17951779Pending
- Engineered Biosynthetic Pathways For Production Of 3,4-DIHYDROXYBENZOIC Acid By FermentationJun 8, 2023 · Application 17917221Pending
- Prioritizing Potential Nodes For Editing Or Potential Edits To A Node For Strain EngineeringJun 1, 2023 · Application 17420629Pending
- Circular-permuted Nucleic Acids For Homology-directed EditingMay 25, 2023 · Application 17918525Pending
- Compositions And Methods For Activating Silent Gene ClustersApr 4, 2023 · US 11,618,898Granted
- Metabolite FingerprintingMar 16, 2023 · Application 17988043Pending
- Selecting Biological Sequences For Screening To Identify Sequences That Perform A Desired FunctionMar 9, 2023 · Application 17760388Pending
- Genome Editing Using Crispr In CorynebacteriumMar 9, 2023 · Application 17817223Pending
- Device-agnostic System For Planning And Executing High-throughput Genomic Manufacturing OperationsFeb 14, 2023 · US 11,581,064Granted
- Identifying Organisms For Production Using Unsupervised Parameter Learning For Outlier DetectionFeb 7, 2023 · US 11,574,153Granted
- Filament Comprising A Thermoplastic Polyimide And Three-dimensional Body Made From The FilamentJan 26, 2023 · Application 17810088Pending
- Genetic Perturbation Of The Rna Degradosome Protein ComplexJan 10, 2023 · US 11,549,096Granted
- Genomic Engineering Of Biosynthetic Pathways Leading To Increased NadphDec 6, 2022 · US 11,519,012Granted
- Compositions And Methods For Synthesis Of TerpenoidsNov 10, 2022 · Application 17622619Pending
- Metagenomic Library And Natural Product Discovery PlatformNov 8, 2022 · US 11,495,326Granted
- Systems And Methods For High-throughput Automated Strain Generation For Non-sporulating FungiOct 25, 2022 · US 11,479,779Granted
- Downscaling Parameters To Design Experiments And Plate Models For Micro-organisms At Small Scale To Improve Prediction Of Performance At Larger ScaleOct 13, 2022 · Application 17608871Pending
- Promoters From Corynebacterium GlutamicumOct 13, 2022 · Application 17704917Pending
Related companies, and why
- VASCULAR VISION PHARMACEUTICAL COSimilar federal contract value in Biotech · $289K in contracts
- Organovo, Inc.Similar federal contract value in Biotech · $284K in contracts
- SYMBERIX, INC.Similar federal contract value in Biotech · $269K in contracts
- LEXICON PHARMACEUTICALS, INC.Similar federal contract value in Biotech · $263K in contracts
- AllCells, LLCSimilar federal contract value in Biotech · $261K in contracts
- Optys Tech CorporationSimilar federal contract value in Biotech · $252K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .